Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Construction In Progress: HK$0.0 Mil (As of Dec. 2025)


HKSE:08049 Jilin Province Huinan Changlong Bio-pharmacy Co Ltd HKSE:08049
81 GF Score
Price HK$2.31
GF Value HK$1.66
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Jilin Province Huinan Changlong Bio-pharmacy Co Construction In Progress?

Jilin Province Huinan Changlong Bio-pharmacy Co HKSE:08049 +0.43% 81 Construction In Progress is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:08049 with a GF Score™ of 81/100 and a GF Value™ of HK$1.66 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Jilin Province Huinan Changlong Bio-pharmacy Co's annual construction in progress declined from Dec. 2023 (HK$5.4 Mil) to Dec. 2024 (HK$0.0 Mil) but then stayed the same from Dec. 2024 (HK$0.0 Mil) to Dec. 2025 (HK$0.0 Mil).

Jilin Province Huinan Changlong Bio-pharmacy Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Jilin Province Huinan Changlong Bio-pharmacy Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jilin Province Huinan Changlong Bio-pharmacy Co Construction In Progress Chart

Jilin Province Huinan Changlong Bio-pharmacy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 181.05 0.00 5.36 0.00 0.00

Jilin Province Huinan Changlong Bio-pharmacy Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.36 5.28 0.00 0.00 0.00
HKSE:08049
81GF Score
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd HKSE:08049
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jilin Province Huinan Changlong Bio-pharmacy Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of HK$0.0 Mil mean?
Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) has a Construction In Progress of HK$0.0 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors.
Is Jilin Province Huinan Changlong Bio-pharmacy Co's Construction In Progress too high?
Jilin Province Huinan Changlong Bio-pharmacy Co's current Construction In Progress is HK$0.0 Mil. Overall, Jilin Province Huinan Changlong Bio-pharmacy Co has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jilin Province Huinan Changlong Bio-pharmacy Co's Construction In Progress compare to ZTS and UTHR?
Jilin Province Huinan Changlong Bio-pharmacy Co's Construction In Progress of HK$0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. Jilin Province Huinan Changlong Bio-pharmacy Co's current Construction In Progress is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jilin Province Huinan Changlong Bio-pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$1.66, compared to a current price of HK$2.31 — trading 39.2% above its estimated fair value. The current Construction In Progress is HK$0.0 Mil. Jilin Province Huinan Changlong Bio-pharmacy Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049), the current Construction In Progress is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Overvalued in 2026?

Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co stock appears to be overvalued. The current stock price of HK$2.31 is trading 39.2% above its estimated GF Value™ of HK$1.66. GuruFocus considers Jilin Province Huinan Changlong Bio-pharmacy Co to be Significantly Overvalued.

Key valuation signals for HKSE:08049:

  • Construction In Progress: HK$0.0 Mil
  • GF Value™: HK$1.66 vs. price of HK$2.31 (39.2% above fair value)
  • GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the HKSE:08049 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jilin Province Huinan Changlong Bio-pharmacy Co Business Description

Other Exchanges JIL:Germany
Address 625 & 639 Nathan Road, Room 1101-2, 11th Floor, Office Tower Two, Grand Plaza, Mong kok, Kowloon, Hong Kong, HKG
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
81GF Score

Get the complete analysis for HKSE:08049

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.31
Price
HK$1.66
GF Value